Stocks · Health care · Pharmaceutical Preparations

Disc Medicine, Inc.

IRON Clue Score26
United States Fiscal year ends December CIK 0001816736 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Kevin Bitterman
11 Sep 2026
Director
Sold after exercise
27,136
$70.11
$1.90M
Jonathan Yen-Wen Yu
25 Aug 2026
Chief Operating Officer
Sold after exercise
8,796
$83.12
$731.09K
Jonathan Yen-Wen Yu
24 Aug 2026
Chief Operating Officer
Sold after exercise
300
$82.53
$24.76K
John D Quisel
17 Aug 2026
Chief Executive Officer
Sold after exercise
11,888
$79.84
$949.16K
John D Quisel
17 Aug 2026
Chief Executive Officer
Sold after exercise
12,712
$79.20
$1.01M
John D Quisel
17 Aug 2026
Chief Executive Officer
Sold after exercise
8,400
$78.11
$656.09K
Jonathan Yen-Wen Yu
12 Aug 2026
Chief Operating Officer
Sold after exercise
804
$82.64
$66.44K
Rahul Khara
6 Aug 2026
Chief Legal Officer
Sold after exercise
5,000
$80.00
$400.00K
John D Quisel
13 Jul 2026
Chief Executive Officer
Sold after exercise
6,400
$76.05
$486.73K
John D Quisel
13 Jul 2026
Chief Executive Officer
Sold after exercise
16,896
$74.95
$1.27M
John D Quisel
13 Jul 2026
Chief Executive Officer
Sold after exercise
9,704
$74.27
$720.74K
Jonathan Yen-Wen Yu
7 Jul 2026
Chief Operating Officer
Sold after exercise
100
$82.50
$8.25K
Rahul Khara
29 Jun 2026
Chief Legal Officer
Sold after exercise
1,649
$75.00
$123.68K
Jonathan Yen-Wen Yu
26 Jun 2026
Chief Operating Officer
Sold after exercise
300
$72.50
$21.75K
Rahul Khara
26 Jun 2026
Chief Legal Officer
Sold after exercise
851
$75.00
$63.83K
Jonathan Yen-Wen Yu
22 Jun 2026
Chief Operating Officer
Sold after exercise
9,700
$72.66
$704.80K
John D Quisel
18 Jun 2026
Chief Executive Officer
Sold after exercise
1,551
$71.61
$111.07K
John D Quisel
18 Jun 2026
Chief Executive Officer
Sold after exercise
9,522
$70.70
$673.21K
John D Quisel
18 Jun 2026
Chief Executive Officer
Sold after exercise
22,927
$69.92
$1.60M
Rahul Khara
18 Jun 2026
Chief Legal Officer
Sold after exercise
500
$71.62
$35.81K
Rahul Khara
18 Jun 2026
Chief Legal Officer
Sold after exercise
1,600
$70.73
$113.16K
Rahul Khara
18 Jun 2026
Chief Legal Officer
Sold after exercise
5,400
$69.94
$377.69K
Jonathan Yen-Wen Yu
16 Jun 2026
Chief Operating Officer
Sold after exercise
6,961
$69.92
$486.70K
Jonathan Yen-Wen Yu
16 Jun 2026
Chief Operating Officer
Sold after exercise
11,651
$68.76
$801.10K
Rahul Khara
20 Jan 2026
Chief Legal Officer
Sold after exercise
1,000
$69.74
$69.74K
Rahul Khara
2 Jan 2026
Chief Legal Officer
Sold after exercise
1,157
$79.27
$91.72K
Rahul Khara
2 Jan 2026
Chief Legal Officer
Sold after exercise
4,993
$78.62
$392.57K
Rahul Khara
2 Jan 2026
Chief Legal Officer
Sold after exercise
350
$77.67
$27.18K
Kevin Bitterman
15 Dec 2025
Director
Sold after exercise
7,000
$91.87
$643.09K
Kevin Bitterman
15 Dec 2025
Director
Sold after exercise indirect
1,572
$92.01
$144.64K
Kevin Bitterman
15 Dec 2025
Director
Sold after exercise indirect
11,427
$91.18
$1.04M
Kevin Bitterman
15 Dec 2025
Director
Sold after exercise indirect
2,049
$92.01
$188.53K
Kevin Bitterman
15 Dec 2025
Director
Sold after exercise indirect
14,811
$91.18
$1.35M
Kevin Bitterman
15 Dec 2025
Director
Sold after exercise indirect
3,921
$92.01
$360.77K
Kevin Bitterman
15 Dec 2025
Director
Sold after exercise indirect
28,913
$91.18
$2.64M
John D Quisel
11 Dec 2025
Chief Executive Officer
Sold after exercise
16,888
$93.65
$1.58M
John D Quisel
11 Dec 2025
Chief Executive Officer
Sold after exercise
16,356
$92.96
$1.52M
John D Quisel
11 Dec 2025
Chief Executive Officer
Sold after exercise
4,337
$92.21
$399.92K
John D Quisel
11 Dec 2025
Chief Executive Officer
Sold after exercise
2,419
$90.97
$220.06K
Jonathan Yen-Wen Yu
11 Nov 2025
Chief Operating Officer
Sold after exercise
8,040
$85.91
$690.74K
Jonathan Yen-Wen Yu
11 Nov 2025
Chief Operating Officer
Sold after exercise
9,360
$85.33
$798.69K
Jonathan Yen-Wen Yu
11 Nov 2025
Chief Operating Officer
Sold after exercise
4,585
$83.99
$385.08K
Jonathan Yen-Wen Yu
11 Nov 2025
Chief Operating Officer
Sold after exercise
8,015
$83.15
$666.41K

What was left out

Form 4 filings counted 49
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 37
Sales straight out of an exercise 43
Sales at will 20
Transactions with no price 0
Shares from compensation/vesting 458,891
History held since 19 Oct 2020